Overview

Trial of Montelukast in Eosinophilic Esophagitis

Status:
Completed

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

Evaluate clinical effectiveness of oral montelukast compared to placebo on prevention of dysphagia and food impaction in patients with EE. Also evaluate tolerance and safety of oral montelukast in treatment of EE.

Phase:

Phase 1

Details

Lead Sponsor:

Mayo Clinic

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Montelukast